S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

NCT00100789 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

NETWORK

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: gemcitabine
DRUG: paclitaxel

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]